Quaker BioVentures

Quaker BioVentures is a venture capital firm investing in life science companies. The firm leads investments across the spectrum of the

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Detailed Quaker BioVentures Information

Geographic Data

Quaker BioVentures headquarters map

Address:

City:

State:

Zip:

Country:

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Quaker BioVentures is a venture capital firm investing in life science companies. The firm leads investments across the spectrum of the life science industry, including biopharmaceuticals, medical devices, human diagnostics, specialty pharmaceuticals, and healthcare services. Quaker BioVentures invests in companies at all stages of development, from early stage start-ups to public companies. Founded in 2003, the firm is currently investing Quaker BioVentures II, a $420 million fund formed in 2007. Quaker BioVentures manages over $700 million in committed capital.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
10/2008 Biolex Therapeutics Series D 0
5/2005 Celator Pharmaceuticals Series B 20M
9/2012 Intact Vascular Series A 15.5M
3/2006 Nitric Bio Series A 14M
10/2009 Neuronetics Series D 0
12/2009 Regado Biosciences Series D 0
10/2008 Corridor Pharmaceuticals Seed Round 0
1/2011 TetraLogic Pharmaceuticals Series C 0
8/2003 Biolex Therapeutics Venture Round 0
6/2007 Argolyn Bioscience Series A 15.8M
4/2013 RainDance Technologies Series E 0
11/2008 Tengion Series C 0
3/2007 Regado Biosciences Series C 23M
12/2002 BioRexis Series A 8M
6/2011 NovaSom Series D 35M
3/2006 Helomics Venture Round 20M
6/2010 Helomics Series D 33M
4/2004 MedMark Treatment Centers Venture Round 28M
8/2009 Rapid Micro Biosystems Series A 18.6M
6/2006 TetraLogic Pharmaceuticals Series B 36M
7/2008 Celator Pharmaceuticals Series C 22.5M
1/2010 Tarsa Therapeutics Series A 24M
2/2005 Neotropix Series A 10M
3/2008 EKR Therapeutics Series D 50M
9/2013 PreCision Dermatology Debt Financing 67M
3/2004 BioRexis Series B 30M
9/2010 Celator Pharmaceuticals Series D 0
8/2007 Celator Pharmaceuticals Series C 10M
5/2010 TearScience Series C 44.5M
10/2007 Tengion Series C 33M
6/2006 Tengion Series B 50M
1/2010 BioLeap Series A 5M
9/2006 Amicus Therapeutics Series D 60M
6/2004 Nucleonics Series B 49.2M
6/2009 Cempra Series C 46M
4/2005 TargetRx Series D 0
9/2005 Amicus Therapeutics Series C 55M
8/2010 TetraLogic Pharmaceuticals Series C 0
5/2011 Neuronetics Series E 30M
4/2015 Neuronetics Series F 0
9/2005 Biolex Therapeutics Series B 36M
5/2007 Biolex Therapeutics Series C 30M
6/2010 Corridor Pharmaceuticals Series A 0
11/2008 Helomics Venture Round 43M
10/2009 Asensus Surgical Post-IPO Equity 0
3/2019 Kaarta Series A 0
3/2012 Tarsa Therapeutics Series B 28M
4/2008 Transave Series D 35M
7/2008 NuPathe Series B 30M
8/2007 EKR Therapeutics Series C 13M
5/2005 Tranzyme Series A -
4/2008 Diasome Pharmaceuticals Series B 8.4M
10/2009 Sleep Solutions Series F 20M
4/2007 StageMark Series B 1.6M
10/2007 Optherion Series A 37M
1/2011 RainDance Technologies Series D 37.5M
8/2010 Achillion Pharmaceuticals Post-IPO Equity 50.1M
11/2007 Tranzyme Venture Round 20M
3/2019 Kaarta Series A 0
4/2015 Neuronetics Series F 0
9/2013 PreCision Dermatology Debt Financing 0
4/2013 RainDance Technologies Series E 0
9/2012 Intact Vascular Series A 0
3/2012 Tarsa Therapeutics Series B 0
6/2011 NovaSom Series D 0
5/2011 Neuronetics Series E 0
1/2011 RainDance Technologies Series D 0
1/2011 TetraLogic Pharmaceuticals Series C 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research
CoBee's Logo
Copyright © CoBee 2022. All Rights Reserved.